Search Results - "Schaaf, Lea"
-
1
Renal effects of metallothionein induction by zinc in vitro and in vivo
Published in BMC nephrology (16-03-2017)“…Metallothionein (MTT) is an endogenous antioxidant that can be induced by both zinc (Zn) and ischemia. In kidneys, increased MTT expression exerts a putative…”
Get full text
Journal Article -
2
Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma
Published in British journal of haematology (01-05-2017)“…Summary Imbalances in the composition of BCL2 family proteins contribute to tumourigenesis and therapy resistance of mantle cell lymphoma (MCL), making these…”
Get full text
Journal Article -
3
Hyperthermia Synergizes with Chemotherapy by Inhibiting PARP1-Dependent DNA Replication Arrest
Published in Cancer research (Chicago, Ill.) (15-05-2016)“…Although hyperthermia offers clinical appeal to sensitize cells to chemotherapy, this approach has been limited in terms of long-term outcome as well as…”
Get full text
Journal Article -
4
Abstract 2223: Membranous expression of programmed cell death-ligand 1 (PDL1) on cancer cells is induced by cisplatin in an ATR dependent manner
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Cancer cells frequently develop strategies allowing to escape potential immune attacks by the host. One central component of this defense mechanism is the…”
Get full text
Journal Article -
5
Abstract 2747: PARP inhibitors act synergistically with cisplatin and doxorubicin in BRCA competent cells by compromising chemotherapy-induced replication arrest
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…PARP inhibitors as monotherapy have emerged as promising antitumor drugs in particular for malignancies with nonfunctional BRCA1/2 proteins. Furthermore,…”
Get full text
Journal Article -
6
A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC
Published in Annals of surgical oncology (01-12-2015)“…Background Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery is a radical but effective treatment option for patients with…”
Get full text
Journal Article -
7
Abstract 3630: Inhibition of PARP by hyperthermia or pharmacological inhibitors synergize with cisplatin and doxorubicin but not with 5-FU or paclitaxel
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Short-term, high-dose chemotherapy together with hyperthermia (HIPEC) is widely used for treatment of peritoneal carcinomatosis. However, it is fairly known…”
Get full text
Journal Article -
8
Abstract 3787: Effects of hyperthermia on DNA repair capacity and long term survival in ovarian and colon carcinoma cells
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Background: Gynecological and gastrointestinal malignancies have the potential to spread into the peritoneal cavity. Peritoneal carcinomatosis is associated…”
Get full text
Journal Article -
9
Abstract 2574: HIPEC for treatment of peritoneal carcinomatosis: 40°C is the critical threshold temperature for potentiating chemotherapy efficacy in vitro and in vivo
Published in Cancer research (Chicago, Ill.) (01-08-2015)“…Hyperthermic intraperitoneal chemotherapy (HIPEC) combines circulated chemotherapy with enhanced temperature in the abdominal cavity of peritoneal carcinosis…”
Get full text
Journal Article -
10
Abstract 3732: Combined targeting of NOXA and GSTpi effectively kills mantle cell lymphoma cells
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Mantle cell lymphoma (MCL) is clinically characterized by an aggressive course and only transient response to chemotherapy. Therefore, new treatment strategies…”
Get full text
Journal Article